$5.61
0.142.56%
At Close: -
$5.55
-0.06-1.04%
After Hours: Jul 5, 7:41 PM EDT
15 minutes delayed
Aurinia Pharmaceuticals
AUPHNASDAQ
Aurinia Pharmaceuticals (NASDAQ:AUPH) Stock, Earnings Estimates, EPS, And Revenue
Aurinia Pharmaceuticals reports earnings on a quarterly basis. These quarterly earnings reports give investors a glimpse into financial results from a company for a 3 month period. Earnings reports almost always include EPS and Revenue results.
Earnings Date
Aug 1
EPS Estimate
$0.010
Quarterly Revenue Estimate
$55M
Annual Revenue
(as of Mar 31)
(as of Mar 31)
$191.4M
Analyze the earnings history of Aurinia Pharmaceuticals using advanced sorting and filters.
| Get Alert | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| AUPH | Aurinia Pharmaceuticals | -$0.08 | $0.01 | — | — | $41.49M | $55.05M | — | — | 08/01/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.14 | -$0.03 | 78.57% | $34.41M | $47.45M | $50.30M | 6.01% | 05/02/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.18 | -$0.16 | -$0.19 | -18.75% | $28.43M | $44.45M | $45.09M | 1.45% | 02/15/2024 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | -$0.17 | -$0.09 | 47.06% | $55.78M | $38.50M | $54.52M | 41.60% | 11/02/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.20 | -$0.08 | 60.00% | $28.19M | $36.37M | $41.49M | 14.09% | 08/03/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.27 | -$0.22 | -$0.18 | 18.18% | $21.63M | $27.87M | $34.41M | 23.46% | 05/04/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.25 | -$0.27 | -$0.18 | 33.33% | $23.40M | $27.78M | $28.43M | 2.36% | 02/28/2023 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.39 | -$0.17 | -$0.06 | 64.71% | $14.67M | $36.18M | $55.78M | 54.17% | 11/03/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.37 | -$0.22 | -$0.25 | -13.64% | $6.62M | $27.14M | $28.19M | 3.87% | 08/04/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.40 | -$0.27 | -$0.27 | 0.00% | $914.00K | $19.76M | $21.63M | 9.44% | 05/10/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.06 | — | -$0.25 | — | $50.03M | — | $23.40M | — | 02/28/2022 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.28 | -$0.33 | -$0.39 | -18.18% | $29.00K | $13.88M | $14.67M | 5.67% | 11/03/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.26 | -$0.14 | -$0.37 | -164.29% | $29.00K | $40.00K | $6.62M | 16450.00% | 08/05/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.23 | -$0.14 | -$0.40 | -185.71% | $30.00K | $40.00K | $914.00K | 2185.00% | 05/06/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.29 | -$0.14 | -$0.05 | 64.29% | $29.00K | $40.00K | $50.03M | 124975.00% | 02/24/2021 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.21 | -$0.15 | -$0.28 | -86.67% | $230.00K | $50.00K | $29.00K | -42.00% | 11/10/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.17 | -$0.14 | -$0.26 | -85.71% | $29.00K | $40.00K | $29.00K | -27.50% | 08/11/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.14 | -$0.15 | -$0.15 | 0.00% | $30.00K | $50.00K | $30.00K | -40.00% | 05/14/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.17 | -$0.15 | -$0.29 | -93.33% | $29.00K | $50.00K | $29.00K | -42.00% | 03/05/2020 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.21 | -$0.15 | -$0.21 | -40.00% | $375.00K | $50.00K | $230.00K | 360.00% | 11/14/2019 | Get Alert |
| AUPH | Aurinia Pharmaceuticals | -$0.19 | — | -$0.17 | — | $29.00K | — | $29.00K | — | 08/06/2019 | Get Alert |
Aurinia Pharmaceuticals (AUPH) Earnings Per Share
Quarterly Earnings Surprise Amount
| Fiscal Quarter End | Date Reported | Actual EPS | Estimated EPS | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $-0.03 | $-0.14 | 78.6 % |
| Dec 2023 | 2024-02-15 | $-0.19 | $-0.16 | -18.8 % |
| Sep 2023 | 2023-11-02 | $-0.09 | $-0.17 | 47.1 % |
| Jun 2023 | 2023-08-03 | $-0.08 | $-0.20 | 60.0 % |
Aurinia Pharmaceuticals (AUPH) Revenue
Quarterly Revenue Surprise Amount
| Fiscal Quarter End | Date Reported | Actual Revenue | Estimated Revenue | Surprise % |
|---|---|---|---|---|
| Mar 2024 | 2024-05-02 | $50.30M | $47.45M | 6.01 % |
| Dec 2023 | 2024-02-15 | $45.10M | $44.45M | 1.45 % |
| Sep 2023 | 2023-11-02 | $54.52M | $38.50M | 41.6 % |
| Jun 2023 | 2023-08-03 | $41.49M | $36.37M | 14.1 % |
FAQ
When is Aurinia Pharmaceuticals (NASDAQ:AUPH) reporting earnings?
Aurinia Pharmaceuticals (AUPH) is scheduled to report earnings on August 1, 2024. The last reported earnings were for reported on May 2, 2024 for Q1.
What were the latest earnings per share (EPS) for Aurinia Pharmaceuticals (NASDAQ:AUPH)?
The Actual EPS was $-0.03, which beat the estimate of $-0.14.
What were Aurinia Pharmaceuticals’s (NASDAQ:AUPH) revenues?
The Actual Revenue was $50.3M, which beat the estimate of $47.5M.
Browse earnings estimates, EPS, and revenue on all stocks.